Suppressed drug metabolism was identified in patients with various inflammatory conditions.
About four of every five patients with COVID-19-related olfactory loss report smell recovery within six months.
Free menstrual pads and tampons must be provided in restrooms at all California public schools and colleges starting in the 2022-2023 academic year.
Merck & Co. announced that it had submitted an application with the FDA for emergency use approval of the first antiviral pill targeted to COVID-19.
The Functional Pain Scale is a reliable and consistent patient-reported measure of pain.
Zimhi is intended for immediate administration as emergency therapy in settings where opioids may be present.
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Health care workers experienced higher levels of stress than other occupations in the first wave of the COVID-19 pandemic.
Discharge from the hospital is associated with an acute increase in the risk for opioid-related deaths in England.
Gut dysbiosis may contribute to the development of distal neuropathic pain in people living with HIV.